Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 1.500% 4/1
-
Number of holders
-
24
-
Total 13F principal, excl. options
-
172M
-
Principal change
-
-22.2M
-
Total reported value, excl. options
-
$233M
-
Value change
-
-$29M
-
Number of buys
-
6
-
Number of sells
-
-8
-
Price
-
$1.10
Significant Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q4 2021
29 filings reported holding 19249HAB9 - COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q4 2021.
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 has 24 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $172M of principal
.
Largest 10 bondholders include CITADEL ADVISORS LLC ($35.4M of principal), LAZARD ASSET MANAGEMENT LLC ($26M of principal), UBS ASSET MANAGEMENT AMERICAS INC ($23.5M of principal), Opti Capital Management, LP ($17.7M of principal), AQR Arbitrage LLC ($14.6M of principal), WOLVERINE ASSET MANAGEMENT LLC ($14.5M of principal), D. E. Shaw & Co., Inc. ($10.5M of principal), CALAMOS ADVISORS LLC ($5.47M of principal), SHENKMAN CAPITAL MANAGEMENT INC ($4.68M of principal), and PERCEPTIVE ADVISORS LLC ($4.5M of principal).
This table shows the top 24 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.